Compare Pfizer Inc (PFE) vs Vanguard Ultra Short Bond ETF (VUSB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Vanguard Ultra Short Bond ETF — how do they compare? Pfizer Inc trades at $24.91 (market cap $142.14B), while Vanguard Ultra Short Bond ETF trades at $49.66. The key difference: Pfizer Inc pays a 6.9% dividend while Vanguard Ultra Short Bond ETF pays none, and Pfizer Inc is trading nearer its 52-week high, Vanguard Ultra Short Bond ETF nearer its low. Which is the better fit depends on your goals.
| PFE | VUSB | |
|---|---|---|
Market Cap | $142.14B | — |
Volume | 29,869,932 | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $28.56 | $50.03 |
52-Week Low | $23.29 | $49.60 |
Enterprise Value | $192.80B | — |
Dividend Yield | 6.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $24.83, up 0.32% today, with a neutral technical signal and bearish moving averages. The company reported revenue of $62.58B in 2025, with a net income margin of 11.83%, and has beaten EPS estimates for the last three quarters. Recent news highlights pipeline developments in oncology and obesity, with a consensus analyst price target of $28.25.
PFE offers a stable dividend and trades below analyst targets, but faces headwinds from patent expirations and volatile cash flows. The stock presents value with a P/E of 19.04, though growth depends on successful drug launches and navigating post-COVID revenue normalization.
VUSB trades at $49.70, showing minimal daily movement with a slight 0.02% gain. The technical outlook is mixed, with a bullish overall signal but bearish moving averages. Recent dividend payments of $0.17-$0.18 per share indicate ongoing shareholder returns. Financial media highlights potential benefits from Federal Reserve policy shifts favoring short-term bonds.
The outlook remains cautiously optimistic given the ETF's focus on short-term bonds amid potential rate hikes. Key risks include interest rate sensitivity and market volatility. Analyst sentiment appears balanced, with technical indicators suggesting near-term consolidation around current price levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Vanguard Ultra Short Bond ETF
VUSB is an actively managed ETF from Vanguard that invests in a diversified portfolio of high-quality, investment-grade fixed income securities with maturities typically under two years. It is designed to offer higher yield potential than traditional money market funds while maintaining limited price volatility, making it a strategic tool for managing short-term reserves with a 6-to-18-month horizon.
Read more on VUSB →
